The newest trial is titled Leuprolide plus Cholinesterase Inhibition to reduce Neurological Decline in Alzheimer’s, or LUCINDA for short. After seeing positive results with an earlier study, researchers are working to build a larger body of evidence to show if the treatment is working.
University Communications